As of today (2024-04-16), IDEXX Laboratories's share price is $490.14.
IDEXX Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.80. Hence, IDEXX Laboratories's Price-to-Operating-Cash-Flow Ratio for today is 45.40.
The historical rank and industry rank for IDEXX Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:
IDXX'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 20.22 Med: 46.11 Max: 78.15
Current: 45.41
During the past 13 years, IDEXX Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 78.15. The lowest was 20.22. And the median was 46.11.
IDEXX Laboratories's Cash Flow from Operations per share for the
three
months ended in Dec. 2023 was $2.98.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.80.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of IDEXX Laboratories was 68.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 13.00% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.70% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 17.10% per year.
During the past 13 years, IDEXX Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 86.50% per year. The lowest was -6.80% per year. And the median was 16.30% per year.
IDEXX Laboratories Price-to-Operating-Cash-Flow Historical Data
The historical data trend for IDEXX Laboratories's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
|
IDEXX Laboratories Annual Data
|
|
Trend |
Dec14 |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
49.79 |
66.89 |
75.45 |
63.56 |
51.42 |
|
IDEXX Laboratories Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Price-to-Operating-Cash-Flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
63.56 |
68.67 |
56.49 |
44.22 |
51.42 |
Competitive Comparison
For the Diagnostics & Research subindustry, IDEXX Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories Price-to-Operating-Cash-Flow Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's Price-to-Operating-Cash-Flow falls into.
IDEXX Laboratories Price-to-Operating-Cash-Flow Calculation
IDEXX Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 490.14 | / | 10.795 |
| = | 45.40 |
IDEXX Laboratories's Share Price of today is $490.14.
IDEXX Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.80.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
IDEXX Laboratories (IDEXX Laboratories) Business Description
Traded in Other Exchanges
Address
One IDEXX Drive, Westbrook, ME, USA, 04092
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.
Executives
| James F Polewaczyk |
officer: Corporate Vice President |
IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092 |
| Jonathan Jay Mazelsky |
director, officer: President and CEO |
ONE IDEXX DRIVE, WESTBROOK ME 04092 |
| Martin Alexander Smith |
officer: Executive Vice President |
C/O IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092 |
| Jonathan W Ayers |
director, officer: President & CEO |
IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092 |
| Michael Lane |
officer: Executive Vice President |
C/O IDEXX LABORATORIES, INC., WESTBROOK ME 04092 |
| Irene Chang Britt |
director |
CAMPBELL SOUP COMPANY, ONE CAMPBELL PLACE, CAMDEN NJ 08103 |
| Bruce L. Claflin |
director |
7035 RIDGE ROAD, HANOVER MD 21076 |
| Samer Abdul Samad |
director |
5200 ILLUMINA WAY, SAN DIEGO CA 92122 |
| Stuart Essig |
director |
311 C ENTERPRISE DRIVE, PLAINSBORO NJ 08536 |
| Lawrence D Kingsley |
director |
C/O IDEX CORPORATION, 630 DUNDEE ROAD, NORTHBROOK IL 60062 |
| Asha Collins |
director |
IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092 |
| M Anne Szostak |
director |
C/O TUPPERWARE BRANDS CORP, 14901 S ORANGE BLOSSOM TR, ORLANDO FL 32837 |
| Sharon E. Underberg |
officer: EVP, GC & Corporate Secretary |
EASTMAN KODAK COMPANY, 343 STATE STREET, ROCHESTER NY 14650 |
| Sophie V. Vandebroek |
director |
6 OAK MEADOW ROAD, LINCOLN MA 01770 |
| Daniel M Junius |
director |
C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM MA 02451 |
IDEXX Laboratories (IDEXX Laboratories) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXX has been successfully added to your